APO Research
Talk to an analyst

APO RESEARCH · REPORT

Irritable Bowel Syndrome Treatment Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Irritable Bowel Syndrome Treatment Drug Industry Growth and Trends Forecast to 2032

20 December 2025100 pages

Choose your research edition.

Industry ResearchIrritable Bowel Syndrome Treatment Drug Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Irritable Bowel Syndrome Treatment Drug Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Irritable Bowel Syndrome Treatment Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Irritable Bowel Syndrome Treatment Drug Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Irritable Bowel Syndrome Treatment Drug Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

According to APO Research, the global Irritable Bowel Syndrome Treatment Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Irritable Bowel Syndrome Treatment Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Irritable Bowel Syndrome Treatment Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Irritable Bowel Syndrome Treatment Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Irritable Bowel Syndrome Treatment Drug market include Takeda Pharmaceutical Ltd, Johnson & Johnson, Roche, Pfizer Inc., Biogen, Abbvie Inc., AstraZeneca, Prometheus Laboratories Inc. (Nestle) and Bristol Myers Squibb, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Irritable Bowel Syndrome Treatment Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Irritable Bowel Syndrome Treatment Drug market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Irritable Bowel Syndrome Treatment Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Irritable Bowel Syndrome Treatment Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Irritable Bowel Syndrome Treatment Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Irritable Bowel Syndrome Treatment Drug Market by Company

Takeda Pharmaceutical Ltd

Johnson & Johnson

Roche

Pfizer Inc.

Biogen

Abbvie Inc.

AstraZeneca

Prometheus Laboratories Inc. (Nestle)

Bristol Myers Squibb

Bausch Health

Irritable Bowel Syndrome Treatment Drug Segment by Type

Corticosteroids

Immunomodulators

Antibiotics

Amino Salicylates

Others

Irritable Bowel Syndrome Treatment Drug Segment by Application

Hospitals

Specialty Clinics

Other

Irritable Bowel Syndrome Treatment Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Irritable Bowel Syndrome Treatment Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Irritable Bowel Syndrome Treatment Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Irritable Bowel Syndrome Treatment Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Irritable Bowel Syndrome Treatment Drug companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Irritable Bowel Syndrome Treatment Drug Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Irritable Bowel Syndrome Treatment Drug Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Irritable Bowel Syndrome Treatment Drug Market Share by Region (2021-2026) Table 4. Global Irritable Bowel Syndrome Treatment Drug Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Irritable Bowel Syndrome Treatment Drug Market Share by Region (2027-2032) Table 6. Global Irritable Bowel Syndrome Treatment Drug Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Irritable Bowel Syndrome Treatment Drug Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Irritable Bowel Syndrome Treatment Drug Market Size Share by Type (2021-2026) Table 9. Global Irritable Bowel Syndrome Treatment Drug Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Irritable Bowel Syndrome Treatment Drug Market Size Share Forecasted by Type (2027-2032) Table 11. North America Irritable Bowel Syndrome Treatment Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Irritable Bowel Syndrome Treatment Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Irritable Bowel Syndrome Treatment Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Irritable Bowel Syndrome Treatment Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Irritable Bowel Syndrome Treatment Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Irritable Bowel Syndrome Treatment Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Irritable Bowel Syndrome Treatment Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Irritable Bowel Syndrome Treatment Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Irritable Bowel Syndrome Treatment Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Irritable Bowel Syndrome Treatment Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Irritable Bowel Syndrome Treatment Drug Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Irritable Bowel Syndrome Treatment Drug Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Irritable Bowel Syndrome Treatment Drug Market Size Share by Application (2021-2026) Table 24. Global Irritable Bowel Syndrome Treatment Drug Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Irritable Bowel Syndrome Treatment Drug Market Size Share Forecasted by Application (2027-2032) Table 26. North America Irritable Bowel Syndrome Treatment Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Irritable Bowel Syndrome Treatment Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Irritable Bowel Syndrome Treatment Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Irritable Bowel Syndrome Treatment Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Irritable Bowel Syndrome Treatment Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Irritable Bowel Syndrome Treatment Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Irritable Bowel Syndrome Treatment Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Irritable Bowel Syndrome Treatment Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Irritable Bowel Syndrome Treatment Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Irritable Bowel Syndrome Treatment Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Irritable Bowel Syndrome Treatment Drug Industry Trends Table 37. Irritable Bowel Syndrome Treatment Drug Industry Drivers Table 38. Irritable Bowel Syndrome Treatment Drug Industry Opportunities and Challenges Table 39. Irritable Bowel Syndrome Treatment Drug Industry Restraints Table 40. Global Irritable Bowel Syndrome Treatment Drug Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Irritable Bowel Syndrome Treatment Drug Revenue Market Share by Company (2021-2026) Table 42. Global Irritable Bowel Syndrome Treatment Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Irritable Bowel Syndrome Treatment Drug Key Company Headquarters & Area Served Table 44. Global Irritable Bowel Syndrome Treatment Drug Company, Product Type & Application Table 45. Global Irritable Bowel Syndrome Treatment Drug Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Irritable Bowel Syndrome Treatment Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Takeda Pharmaceutical Ltd Company Information Table 49. Takeda Pharmaceutical Ltd Business Overview Table 50. Takeda Pharmaceutical Ltd Irritable Bowel Syndrome Treatment Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Takeda Pharmaceutical Ltd Irritable Bowel Syndrome Treatment Drug Product Portfolio Table 52. Takeda Pharmaceutical Ltd Recent Development Table 53. Johnson & Johnson Company Information Table 54. Johnson & Johnson Business Overview Table 55. Johnson & Johnson Irritable Bowel Syndrome Treatment Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Johnson & Johnson Irritable Bowel Syndrome Treatment Drug Product Portfolio Table 57. Johnson & Johnson Recent Development Table 58. Roche Company Information Table 59. Roche Business Overview Table 60. Roche Irritable Bowel Syndrome Treatment Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Roche Irritable Bowel Syndrome Treatment Drug Product Portfolio Table 62. Roche Recent Development Table 63. Pfizer Inc. Company Information Table 64. Pfizer Inc. Business Overview Table 65. Pfizer Inc. Irritable Bowel Syndrome Treatment Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Pfizer Inc. Irritable Bowel Syndrome Treatment Drug Product Portfolio Table 67. Pfizer Inc. Recent Development Table 68. Biogen Company Information Table 69. Biogen Business Overview Table 70. Biogen Irritable Bowel Syndrome Treatment Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Biogen Irritable Bowel Syndrome Treatment Drug Product Portfolio Table 72. Biogen Recent Development Table 73. Abbvie Inc. Company Information Table 74. Abbvie Inc. Business Overview Table 75. Abbvie Inc. Irritable Bowel Syndrome Treatment Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Abbvie Inc. Irritable Bowel Syndrome Treatment Drug Product Portfolio Table 77. Abbvie Inc. Recent Development Table 78. AstraZeneca Company Information Table 79. AstraZeneca Business Overview Table 80. AstraZeneca Irritable Bowel Syndrome Treatment Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. AstraZeneca Irritable Bowel Syndrome Treatment Drug Product Portfolio Table 82. AstraZeneca Recent Development Table 83. Prometheus Laboratories Inc. (Nestle) Company Information Table 84. Prometheus Laboratories Inc. (Nestle) Business Overview Table 85. Prometheus Laboratories Inc. (Nestle) Irritable Bowel Syndrome Treatment Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Prometheus Laboratories Inc. (Nestle) Irritable Bowel Syndrome Treatment Drug Product Portfolio Table 87. Prometheus Laboratories Inc. (Nestle) Recent Development Table 88. Bristol Myers Squibb Company Information Table 89. Bristol Myers Squibb Business Overview Table 90. Bristol Myers Squibb Irritable Bowel Syndrome Treatment Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Bristol Myers Squibb Irritable Bowel Syndrome Treatment Drug Product Portfolio Table 92. Bristol Myers Squibb Recent Development Table 93. Bausch Health Company Information Table 94. Bausch Health Business Overview Table 95. Bausch Health Irritable Bowel Syndrome Treatment Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Bausch Health Irritable Bowel Syndrome Treatment Drug Product Portfolio Table 97. Bausch Health Recent Development Table 98. North America Irritable Bowel Syndrome Treatment Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 99. North America Irritable Bowel Syndrome Treatment Drug Market Size by Country (2021-2026) & (US$ Million) Table 100. North America Irritable Bowel Syndrome Treatment Drug Market Share by Country (2021-2026) Table 101. North America Irritable Bowel Syndrome Treatment Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 102. North America Irritable Bowel Syndrome Treatment Drug Market Share Forecast by Country (2027-2032) Table 103. Europe Irritable Bowel Syndrome Treatment Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 104. Europe Irritable Bowel Syndrome Treatment Drug Market Size by Country (2021-2026) & (US$ Million) Table 105. Europe Irritable Bowel Syndrome Treatment Drug Market Share by Country (2021-2026) Table 106. Europe Irritable Bowel Syndrome Treatment Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 107. Europe Irritable Bowel Syndrome Treatment Drug Market Share Forecast by Country (2027-2032) Table 108. Asia-Pacific Irritable Bowel Syndrome Treatment Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 109. Asia-Pacific Irritable Bowel Syndrome Treatment Drug Market Size by Country (2021-2026) & (US$ Million) Table 110. Asia-Pacific Irritable Bowel Syndrome Treatment Drug Market Share by Country (2021-2026) Table 111. Asia-Pacific Irritable Bowel Syndrome Treatment Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 112. Asia-Pacific Irritable Bowel Syndrome Treatment Drug Market Share Forecast by Country (2027-2032) Table 113. Latin America Irritable Bowel Syndrome Treatment Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. Latin America Irritable Bowel Syndrome Treatment Drug Market Size by Country (2021-2026) & (US$ Million) Table 115. Latin America Irritable Bowel Syndrome Treatment Drug Market Share by Country (2021-2026) Table 116. Latin America Irritable Bowel Syndrome Treatment Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. Latin America Irritable Bowel Syndrome Treatment Drug Market Share Forecast by Country (2027-2032) Table 118. Middle East & Africa Irritable Bowel Syndrome Treatment Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. Middle East & Africa Irritable Bowel Syndrome Treatment Drug Market Size by Country (2021-2026) & (US$ Million) Table 120. Middle East & Africa Irritable Bowel Syndrome Treatment Drug Market Share by Country (2021-2026) Table 121. Middle East & Africa Irritable Bowel Syndrome Treatment Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. Middle East & Africa Irritable Bowel Syndrome Treatment Drug Market Share Forecast by Country (2027-2032) Table 123. Research Programs/Design for This Report Table 124. Authors List of This Report Table 125. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Irritable Bowel Syndrome Treatment Drug Product Image Figure 3. Global Irritable Bowel Syndrome Treatment Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Irritable Bowel Syndrome Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 5. Global Irritable Bowel Syndrome Treatment Drug Market Share by Region: 2025 VS 2032 Figure 6. Global Irritable Bowel Syndrome Treatment Drug Market Share by Region (2021-2032) Figure 7. North America Irritable Bowel Syndrome Treatment Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Irritable Bowel Syndrome Treatment Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Irritable Bowel Syndrome Treatment Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Irritable Bowel Syndrome Treatment Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Irritable Bowel Syndrome Treatment Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Corticosteroids Image Figure 13. Global Corticosteroids Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Immunomodulators Image Figure 15. Global Immunomodulators Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Antibiotics Image Figure 17. Global Antibiotics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Amino Salicylates Image Figure 19. Global Amino Salicylates Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Others Image Figure 21. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 22. Global Irritable Bowel Syndrome Treatment Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 23. Global Irritable Bowel Syndrome Treatment Drug Market Share by Type 2025 VS 2032 Figure 24. North America Irritable Bowel Syndrome Treatment Drug Market Size Share by Type (2021-2032) Figure 25. Europe Irritable Bowel Syndrome Treatment Drug Market Size Share by Type (2021-2032) Figure 26. Asia-Pacific Irritable Bowel Syndrome Treatment Drug Market Size Share by Type (2021-2032) Figure 27. Latin America Irritable Bowel Syndrome Treatment Drug Market Size Share by Type (2021-2032) Figure 28. Middle East and Africa Irritable Bowel Syndrome Treatment Drug Market Size Share by Type (2021-2032) Figure 29. Hospitals Image Figure 30. Global Hospitals Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Specialty Clinics Image Figure 32. Global Specialty Clinics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Other Image Figure 34. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Global Irritable Bowel Syndrome Treatment Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Irritable Bowel Syndrome Treatment Drug Market Share by Application 2025 VS 2032 Figure 37. North America Irritable Bowel Syndrome Treatment Drug Market Size Share by Application (2021-2032) Figure 38. Europe Irritable Bowel Syndrome Treatment Drug Market Size Share by Application (2021-2032) Figure 39. Asia-Pacific Irritable Bowel Syndrome Treatment Drug Market Size Share by Application (2021-2032) Figure 40. Latin America Irritable Bowel Syndrome Treatment Drug Market Size Share by Application (2021-2032) Figure 41. Middle East and Africa Irritable Bowel Syndrome Treatment Drug Market Size Share by Application (2021-2032) Figure 42. Global Top 5 and 10 Irritable Bowel Syndrome Treatment Drug Players Market Share by Revenue in 2025 Figure 43. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 44. North America Irritable Bowel Syndrome Treatment Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. North America Irritable Bowel Syndrome Treatment Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. North America Irritable Bowel Syndrome Treatment Drug Market Share by Country (2021-2032) Figure 47. Europe Irritable Bowel Syndrome Treatment Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Irritable Bowel Syndrome Treatment Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Irritable Bowel Syndrome Treatment Drug Market Share by Country (2021-2032) Figure 50. Asia-Pacific Irritable Bowel Syndrome Treatment Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Asia-Pacific Irritable Bowel Syndrome Treatment Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Asia-Pacific Irritable Bowel Syndrome Treatment Drug Market Share by Country (2021-2032) Figure 53. Latin America Irritable Bowel Syndrome Treatment Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Irritable Bowel Syndrome Treatment Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Irritable Bowel Syndrome Treatment Drug Market Share by Country (2021-2032) Figure 56. Middle East & Africa Irritable Bowel Syndrome Treatment Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Middle East & Africa Irritable Bowel Syndrome Treatment Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 58. Middle East & Africa Irritable Bowel Syndrome Treatment Drug Market Share by Country (2021-2032) Figure 59. Years Considered Figure 60. Research Process Figure 61. Key Executives Interviewed

Scope & coverage.

Types
  • Corticosteroids
  • Immunomodulators
  • Antibiotics
  • Amino Salicylates
  • Others
Applications
  • Hospitals
  • Specialty Clinics
  • Other
Companies covered
  • Takeda Pharmaceutical Ltd
  • Johnson & Johnson
  • Roche
  • Pfizer Inc.
  • Biogen
  • Abbvie Inc.
  • AstraZeneca
  • Prometheus Laboratories Inc. (Nestle)
  • Bristol Myers Squibb
  • Bausch Health

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Irritable Bowel Syndrome Treatment Drug Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Irritable Bowel Syndrome Treatment Drug Market Size by Region (2021-2032)
  5. 1.4.1 Global Irritable Bowel Syndrome Treatment Drug Market Size by Region (2021-2026)
  6. 1.4.2 Global Irritable Bowel Syndrome Treatment Drug Market Size by Region (2027-2032)
  7. 1.5 Key Regions Irritable Bowel Syndrome Treatment Drug Market Size (2021-2032)
  8. 1.5.1 North America Irritable Bowel Syndrome Treatment Drug Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Irritable Bowel Syndrome Treatment Drug Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Irritable Bowel Syndrome Treatment Drug Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Irritable Bowel Syndrome Treatment Drug Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Irritable Bowel Syndrome Treatment Drug Market Size Growth Rate (2021-2032)
2 Irritable Bowel Syndrome Treatment Drug Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Corticosteroids
  3. 2.1.2 Immunomodulators
  4. 2.1.3 Antibiotics
  5. 2.1.4 Amino Salicylates
  6. 2.1.5 Others
  7. 2.2 Global Irritable Bowel Syndrome Treatment Drug Market Size by Type
  8. 2.2.1 Global Irritable Bowel Syndrome Treatment Drug Market Size Overview by Type (2021-2032)
  9. 2.2.2 Global Irritable Bowel Syndrome Treatment Drug Historic Market Size Review by Type (2021-2026)
  10. 2.2.3 Global Irritable Bowel Syndrome Treatment Drug Market Size Forecasted by Type (2027-2032)
  11. 2.3 Global Irritable Bowel Syndrome Treatment Drug Market Size by Regions
  12. 2.3.1 North America Irritable Bowel Syndrome Treatment Drug Market Size Breakdown by Type (2021-2026)
  13. 2.3.2 Europe Irritable Bowel Syndrome Treatment Drug Market Size Breakdown by Type (2021-2026)
  14. 2.3.3 Asia-Pacific Irritable Bowel Syndrome Treatment Drug Market Size Breakdown by Type (2021-2026)
  15. 2.3.4 South America Irritable Bowel Syndrome Treatment Drug Market Size Breakdown by Type (2021-2026)
  16. 2.3.5 Middle East and Africa Irritable Bowel Syndrome Treatment Drug Market Size Breakdown by Type (2021-2026)
3 Irritable Bowel Syndrome Treatment Drug Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Hospitals
  3. 3.1.2 Specialty Clinics
  4. 3.1.3 Other
  5. 3.2 Global Irritable Bowel Syndrome Treatment Drug Market Size by Application
  6. 3.2.1 Global Irritable Bowel Syndrome Treatment Drug Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Irritable Bowel Syndrome Treatment Drug Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Irritable Bowel Syndrome Treatment Drug Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Irritable Bowel Syndrome Treatment Drug Market Size by Regions
  10. 3.3.1 North America Irritable Bowel Syndrome Treatment Drug Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Irritable Bowel Syndrome Treatment Drug Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Irritable Bowel Syndrome Treatment Drug Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Irritable Bowel Syndrome Treatment Drug Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Irritable Bowel Syndrome Treatment Drug Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Irritable Bowel Syndrome Treatment Drug Industry Trends
  2. 4.2 Irritable Bowel Syndrome Treatment Drug Industry Drivers
  3. 4.3 Irritable Bowel Syndrome Treatment Drug Industry Opportunities and Challenges
  4. 4.4 Irritable Bowel Syndrome Treatment Drug Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Irritable Bowel Syndrome Treatment Drug Revenue (2021-2026)
  2. 5.2 Global Irritable Bowel Syndrome Treatment Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Irritable Bowel Syndrome Treatment Drug Key Company Headquarters & Area Served
  4. 5.4 Global Irritable Bowel Syndrome Treatment Drug Company, Product Type & Application
  5. 5.5 Global Irritable Bowel Syndrome Treatment Drug Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Irritable Bowel Syndrome Treatment Drug Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Irritable Bowel Syndrome Treatment Drug Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Irritable Bowel Syndrome Treatment Drug Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Takeda Pharmaceutical Ltd
  2. 6.1.1 Takeda Pharmaceutical Ltd Company Information
  3. 6.1.2 Takeda Pharmaceutical Ltd Business Overview
  4. 6.1.3 Takeda Pharmaceutical Ltd Irritable Bowel Syndrome Treatment Drug Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Takeda Pharmaceutical Ltd Irritable Bowel Syndrome Treatment Drug Product Portfolio
  6. 6.1.5 Takeda Pharmaceutical Ltd Recent Developments
  7. 6.2 Johnson & Johnson
  8. 6.2.1 Johnson & Johnson Company Information
  9. 6.2.2 Johnson & Johnson Business Overview
  10. 6.2.3 Johnson & Johnson Irritable Bowel Syndrome Treatment Drug Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Johnson & Johnson Irritable Bowel Syndrome Treatment Drug Product Portfolio
  12. 6.2.5 Johnson & Johnson Recent Developments
  13. 6.3 Roche
  14. 6.3.1 Roche Company Information
  15. 6.3.2 Roche Business Overview
  16. 6.3.3 Roche Irritable Bowel Syndrome Treatment Drug Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Roche Irritable Bowel Syndrome Treatment Drug Product Portfolio
  18. 6.3.5 Roche Recent Developments
  19. 6.4 Pfizer Inc.
  20. 6.4.1 Pfizer Inc. Company Information
  21. 6.4.2 Pfizer Inc. Business Overview
  22. 6.4.3 Pfizer Inc. Irritable Bowel Syndrome Treatment Drug Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Pfizer Inc. Irritable Bowel Syndrome Treatment Drug Product Portfolio
  24. 6.4.5 Pfizer Inc. Recent Developments
  25. 6.5 Biogen
  26. 6.5.1 Biogen Company Information
  27. 6.5.2 Biogen Business Overview
  28. 6.5.3 Biogen Irritable Bowel Syndrome Treatment Drug Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Biogen Irritable Bowel Syndrome Treatment Drug Product Portfolio
  30. 6.5.5 Biogen Recent Developments
  31. 6.6 Abbvie Inc.
  32. 6.6.1 Abbvie Inc. Company Information
  33. 6.6.2 Abbvie Inc. Business Overview
  34. 6.6.3 Abbvie Inc. Irritable Bowel Syndrome Treatment Drug Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Abbvie Inc. Irritable Bowel Syndrome Treatment Drug Product Portfolio
  36. 6.6.5 Abbvie Inc. Recent Developments
  37. 6.7 AstraZeneca
  38. 6.7.1 AstraZeneca Company Information
  39. 6.7.2 AstraZeneca Business Overview
  40. 6.7.3 AstraZeneca Irritable Bowel Syndrome Treatment Drug Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 AstraZeneca Irritable Bowel Syndrome Treatment Drug Product Portfolio
  42. 6.7.5 AstraZeneca Recent Developments
  43. 6.8 Prometheus Laboratories Inc. (Nestle)
  44. 6.8.1 Prometheus Laboratories Inc. (Nestle) Company Information
  45. 6.8.2 Prometheus Laboratories Inc. (Nestle) Business Overview
  46. 6.8.3 Prometheus Laboratories Inc. (Nestle) Irritable Bowel Syndrome Treatment Drug Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Prometheus Laboratories Inc. (Nestle) Irritable Bowel Syndrome Treatment Drug Product Portfolio
  48. 6.8.5 Prometheus Laboratories Inc. (Nestle) Recent Developments
  49. 6.9 Bristol Myers Squibb
  50. 6.9.1 Bristol Myers Squibb Company Information
  51. 6.9.2 Bristol Myers Squibb Business Overview
  52. 6.9.3 Bristol Myers Squibb Irritable Bowel Syndrome Treatment Drug Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Bristol Myers Squibb Irritable Bowel Syndrome Treatment Drug Product Portfolio
  54. 6.9.5 Bristol Myers Squibb Recent Developments
  55. 6.10 Bausch Health
  56. 6.10.1 Bausch Health Company Information
  57. 6.10.2 Bausch Health Business Overview
  58. 6.10.3 Bausch Health Irritable Bowel Syndrome Treatment Drug Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Bausch Health Irritable Bowel Syndrome Treatment Drug Product Portfolio
  60. 6.10.5 Bausch Health Recent Developments
7 North America
  1. 7.1 North America Irritable Bowel Syndrome Treatment Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Irritable Bowel Syndrome Treatment Drug Market Size by Country (2021-2026)
  3. 7.3 North America Irritable Bowel Syndrome Treatment Drug Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Irritable Bowel Syndrome Treatment Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Irritable Bowel Syndrome Treatment Drug Market Size by Country (2021-2026)
  3. 8.3 Europe Irritable Bowel Syndrome Treatment Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Irritable Bowel Syndrome Treatment Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Irritable Bowel Syndrome Treatment Drug Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Irritable Bowel Syndrome Treatment Drug Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Irritable Bowel Syndrome Treatment Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Irritable Bowel Syndrome Treatment Drug Market Size by Country (2021-2026)
  3. 10.3 South America Irritable Bowel Syndrome Treatment Drug Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Irritable Bowel Syndrome Treatment Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Irritable Bowel Syndrome Treatment Drug Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Irritable Bowel Syndrome Treatment Drug Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst